相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。PSMA3-AS1 induced by transcription factor PAX5 promotes cholangiocarcinoma proliferation, migration and invasion by sponging miR-376a-3p to up-regulate LAMC1
Dongsheng Sun et al.
Aging-US (2022)
Curcumin May Prevent Basement Membrane Disassembly by Matrix Metalloproteinases and Progression of the Bladder Cancer
Pawel Wronski et al.
NUTRIENTS (2022)
Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day
Brigida Anna Maiorano et al.
BIOMEDICINES (2022)
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
Marko Babjuk et al.
EUROPEAN UROLOGY (2022)
Identification of a Twelve Epithelial-Mesenchymal Transition-Related lncRNA Prognostic Signature in Kidney Clear Cell Carcinoma
Qi-Dong Xia et al.
DISEASE MARKERS (2022)
TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer
Ming Chi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
Phycocyanin Ameliorates Colitis-Associated Colorectal Cancer by Regulating the Gut Microbiota and the IL-17 Signaling Pathway
Dongjin Pan et al.
MARINE DRUGS (2022)
Long non-coding RNA BBOX1-antisense RNA 1 enhances cell proliferation and migration and suppresses apoptosis in oral squamous cell carcinoma via the miR-3940-3p/laminin subunit gamma 2 axis
Chunguang Zhao et al.
BIOENGINEERED (2022)
The Clinical Prediction Value of the Ubiquitination Model Reflecting the Immune Traits in LUAD
Yinggang Che et al.
FRONTIERS IN IMMUNOLOGY (2022)
A basement membrane discovery pipeline uncovers network complexity, regulators, and human disease associations
Ranjay Jayadev et al.
SCIENCE ADVANCES (2022)
Matrix Effectors in the Pathogenesis of Keratinocyte-Derived Carcinomas
Rafaela-Maria Kavasi et al.
FRONTIERS IN MEDICINE (2022)
Three hematologic/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis
Qi Cheng et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
Antonio Lopez-Beltran et al.
CANCERS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Relapse of pathological angiogenesis: functional role of the basement membrane and potential treatment strategies
Anthony Mukwaya et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2021)
LINC00649 promotes bladder cancer malignant progression by regulating the miR-15a-5p/HMGA1 axis
Xuanyu Chen et al.
ONCOLOGY REPORTS (2021)
Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancer
Xianchao Sun et al.
CANCER CELL INTERNATIONAL (2021)
Neutrophils Promote Larynx Squamous Cell Carcinoma Progression via Activating the IL-17/JAK/STAT3 Pathway
Tianyi Liu et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2021)
Long noncoding RNA NR2F1-AS1 plays a carcinogenic role in gastric cancer by recruiting transcriptional factor SPI1 to upregulate ST8SIA1 expression
Fang Zuo et al.
BIOENGINEERED (2021)
Potential Immune Biomarker Candidates and Immune Subtypes of Lung Adenocarcinoma for Developing mRNA Vaccines
Yang Wang et al.
FRONTIERS IN IMMUNOLOGY (2021)
Development and Validation of a Prognostic Signature Associated With Tumor Microenvironment Based on Autophagy-Related lncRNA Analysis in Hepatocellular Carcinoma
Yan Deng et al.
FRONTIERS IN MEDICINE (2021)
Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma
Jian-Xuan Sun et al.
DISEASE MARKERS (2021)
Correlations between tumor mutation burden and immune infiltrates and their prognostic value in pancreatic cancer by bioinformatic analysis
Yifan Cai et al.
LIFE SCIENCES (2021)
HIF1α Regulates IL17 Signaling Pathway Influencing Sensitivity of Taxane-Based Chemotherapy for Breast Cancer
Huijuan Dai et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor (vol 9, e002127, 2021)
I De Kouchkovsky et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Long non-coding RNA LINC00649 regulates YES-associated protein 1 (YAP1)/Hippo pathway to accelerate gastric cancer (GC) progression via sequestering miR-16-5p
Hongyan Wang et al.
BIOENGINEERED (2021)
Treatment of muscle-invasive and advanced bladder cancer in 2020
Vaibhav G. Patel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Development and Validation of a Nine-Redox-Related Long Noncoding RNA Signature in Renal Clear Cell Carcinoma
Xia Qi-Dong et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Extracellular Matrix-Related Six-lncRNA Signature as a Novel Prognostic Biomarker for Bladder Cancer
Liangliang Qing et al.
ONCOTARGETS AND THERAPY (2020)
Intrinsic Molecular Subclassification of Urothelial Carcinoma of the Bladder: Are We Finally there?
Mohammed Akhtar et al.
ADVANCES IN ANATOMIC PATHOLOGY (2019)
Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up
Y. Fradet et al.
ANNALS OF ONCOLOGY (2019)
Proteolytic and Opportunistic Breaching of the Basement Membrane Zone by Immune Cells during Tumor Initiation
Maaike C. W. van den Berg et al.
CELL REPORTS (2019)
Identification of prognostic biomarkers in colorectal cancer using a long non-coding RNA-mediated competitive endogenous RNA network
Minjie He et al.
ONCOLOGY LETTERS (2019)
Epidemiology, aetiology and screening of bladder cancer
Marcus G. K. Cumberbatch et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2019)
Burden of unique and low prevalence somatic mutations correlates with cancer survival
Nikolai Klebanov et al.
SCIENTIFIC REPORTS (2019)
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
Thomas Powles et al.
LANCET (2018)
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
Sebastien Antoni et al.
EUROPEAN UROLOGY (2017)
Antisense lncRNA FOXF1-AS1 Promotes Migration and Invasion of Osteosarcoma Cells Through the FOXF1/MMP-2/-9 Pathway
Zhu Kun-Peng et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
Padmanee Sharma et al.
LANCET ONCOLOGY (2017)
Force-dependent breaching of the basement membrane
Tammy T. Chang et al.
MATRIX BIOLOGY (2017)
Pattern recognition for predictive, preventive, and personalized medicine in cancer
Tingting Cheng et al.
EPMA JOURNAL (2017)
Cancer metastases: challenges and opportunities
Xiangming Guan
ACTA PHARMACEUTICA SINICA B (2015)
Ectopic coexpression of keratin 8 and 18 promotes invasion of transformed keratinocytes and is induced in patients with cutaneous squamous cell carcinoma
Yoshito Yamashiro et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Basement membrane proteoglycans: Modulators Par Excellence of cancer growth and angiogenesis
Renato V. Iozzo et al.
MOLECULES AND CELLS (2009)
Metastasis markers in bladder cancer: A review of the literature and clinical considerations
P Gontero et al.
EUROPEAN UROLOGY (2004)
Immunohistochemical demonstration of the gamma 2 chain of laminin-5 in urinary bladder urothelial carcinoma - Impact for diagnosis and prognosis
W Hindermann et al.
CANCER DETECTION AND PREVENTION (2003)